![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Target for obesity drugs comes into focus
Researchers at the University of Michigan have determined how the hormone leptin, an important...
Strategies proposed to improve impact of comparative effectiveness studies
Comparative effectiveness research conducted over the past decade has had a limited impact on...
UCB announces third research collaboration with Harvard University
UCB announced that it has launched a third collaborative research project with Harvard that...
RNA-based therapy brings new hope for an incurable blood cancer
Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer,...
Rare disease researchers notch a win for patients with inherited muscle disease
An older medication originally approved to treat heart problems eases the symptoms of a...
Sanofi and Bristol-Myers Squibb Announce Restructuring of Alliance Agreement
Sanofi and Bristol-Myers Squibb Company have restructured their successful long-term alliance following the loss...
New antibiotic cures disease by disarming pathogens
A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead...
Biological markers increase clinical trial success rate of new breast cancer drugs
Using biological markers - genetic characteristics that are associated with some patients with breast...
Bayer’s Stivarga® (regorafenib) tablets approved by FDA for treatment of metastatic colorectal cancer
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) approved Stivarga® (regorafenib)...
Roche leads healthcare sector in key sustainability index for fourth consecutive year
Roche has been recognised as the most sustainable healthcare company globally in the Dow Jones...